Lantern Pharma (LTRN) Enterprise Value
Price: $3.90
Market Cap: $42.06M
Avg Volume: 91.44K
Market Cap: $42.06M
Avg Volume: 91.44K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Lantern Pharma's latest quarterly financial reports:
- The enterprise value (EV) is 31.69M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 46.41M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $3.67, with 10.76M shares outstanding.
- The company has 8.10M in cash and cash equivalents and 291.24K in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$31.69M
Market Cap
$39.50M
Total Debt
$291.24K
Cash and Equivalents
$8.10M
Historical Enterprise Value
Lantern Pharma Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-09-30.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| September 30, 2024 | $31.69M | -11.66% | $3.67 | 10.76M | $39.50M | $8.10M | $291.24K |
| June 30, 2024 | $35.87M | -57.30% | $4.52 | 10.76M | $48.63M | $12.98M | $218.70K |
| March 31, 2024 | $84.00M | 242.51% | $9.51 | 10.74M | $102.16M | $18.36M | $193.58K |
| December 31, 2023 | $24.52M | 109.14% | $4.28 | 10.80M | $46.23M | $21.94M | $234.47K |
| September 30, 2023 | $11.73M | -64.60% | $3.41 | 10.86M | $37.02M | $25.57M | $274.53K |
| June 30, 2023 | $33.12M | 63.81% | $5.64 | 10.86M | $61.23M | $28.42M | $313.86K |
| March 31, 2023 | $20.22M | -28.59% | $4.83 | 10.86M | $52.44M | $32.48M | $260.22K |
| December 31, 2022 | $28.32M | 123.96% | $6.04 | 10.84M | $65.47M | $37.20M | $52.89K |
| September 30, 2022 | $12.64M | -32.07% | $4.78 | 10.84M | $51.81M | $39.26M | $92.02K |
| June 30, 2022 | $18.61M | -40.49% | $5.71 | 10.83M | $61.84M | $43.36M | $130.71K |
| March 31, 2022 | $31.28M | -17.20% | $7.15 | 10.88M | $77.76M | $46.65M | $168.49K |
| December 31, 2021 | $37.78M | -46.52% | $7.98 | 11.17M | $89.10M | $51.52M | $204.95K |
| September 30, 2021 | $70.63M | -30.87% | $11.18 | 11.19M | $125.06M | $54.67M | $240.98K |
| June 30, 2021 | $102.17M | 0.67% | $14.6 | 11.18M | $163.25M | $61.35M | $276.60K |
| March 31, 2021 | $101.49M | 0.92% | $18.14 | 10.07M | $182.75M | $81.37M | $108.50K |
| December 31, 2020 | $100.57M | 4.27% | $19.25 | 6.22M | $119.69M | $19.23M | $108.50K |
| September 30, 2020 | $96.45M | 781.03% | $18.84 | 6.22M | $117.14M | $20.80M | $108.50K |
| June 30, 2020 | $10.95M | -87.78% | $12.7 | 2.72M | $34.53M | $23.80M | $211.33K |
| March 31, 2020 | $89.58M | -2.34% | $14.95 | 6.03M | $90.16M | $634.25K | $53.27K |
| December 31, 2019 | $91.72M | -1.33% | $14.95 | 6.22M | $92.95M | $1.23M | $- |
| September 30, 2019 | $92.95M | 0.00% | $14.95 | 6.22M | $92.95M | $- | $- |
| June 30, 2019 | $92.95M | -0.48% | $14.95 | 6.22M | $92.95M | $- | $- |
| March 31, 2019 | $93.40M | - | $14.95 | 6.22M | $92.95M | $-445.16K | $- |
Related Metrics
Explore detailed financial metrics and analysis for LTRN.